Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study-Reference-Cited by-同舟云学术

Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study

Published:2017-11-22 Issue:3 Volume:61 Page:201-205
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Hoenigl Martin¹²³⁴^ORCID,Prattes Juergen¹³,Neumeister Peter⁵,Wölfler Albert⁵,Krause Robert¹³

Affiliation:

1. Section of Infectious Diseases and Tropical Medicine; Department of Internal Medicine; Medical University Graz; Graz Austria

2. Division of Pulmonology; Department of Internal Medicine; Medical University of Graz; Graz Austria

3. CBmed - Center for Biomarker Research in Medicine; Graz Austria

4. Division of Infectious Diseases; Department of Medicine; University of California-San Diego; San Diego CA USA

5. Division of Haematology; Department of Internal Medicine; Medical University of Graz; Graz Austria

Funder

Basilea Pharmaceutica International Ltd, Basel, Switzerland

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/myc.12727/fullpdf

Reference28 articles.

1. Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis;Heldt;Mycoses,2017

2. Improving outcome of fungal diseases - guiding experts and patients towards excellence;Cornely;Mycoses,2017

3. European Organization for Research and Treatment of Cancer/InvasiveFungal Infections Cooperative Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group;De Pauw;Clin Infect Dis,2008

4. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients;Blot;Am J Respir Crit Care Med,2012

5. As galactomannan disappoints, our quest for a feasible diagnostic standard for invasive aspergillosis continues;Vehreschild;Am J Respir Crit Care Med,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole;Medical Mycology;2024-08-13

2. Diagnostic accuracy of galactomannan and lateral flow assay in invasive aspergillosis: A diagnostic meta-analysis;Heliyon;2024-07

3. Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic;Journal of Fungi;2024-01-26

4. Pulmonary aspergillus infection with abnormal imaging successfully treated with omalizumab: A case report;Medicine;2023-06-16

5. Therapeutic Approaches for Combating Aspergillus Associated Infection;Current Drug Targets;2022-12